Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Johnson and Johnson
Dow
Medtronic
Merck

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

PTAB Cases for Patent Owner: AstraZeneca AB

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Patent Trial and Appeal Board Cases for Patent Owner: AstraZeneca AB

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,750,237 Lannett Holdings, Inc.   Start Trial 2015-07-28 2015-07-28 AstraZeneca AB Inter partes review   Start Trial 2016-01-27 Alan Dearn   Start Trial
7,220,767 Lannett Holdings, Inc.   Start Trial 2015-07-28 2015-07-28 AstraZeneca AB Inter partes review   Start Trial 2016-02-02 Alan Dearn   Start Trial
RE44,186 Mylan Pharmaceuticals Inc.   Start Trial 2015-06-04 2015-06-04 AstraZeneca AB Inter partes review   Start Trial 2016-05-02 Jeffrey Robl   Start Trial
RE44,186 Wockhardt Bio AG   Start Trial 2016-05-11 2016-05-11 AstraZeneca AB Inter partes review   Start Trial 2016-08-23 Jeffrey Robl   Start Trial
RE44,186 Amneal Pharmaceuticals LLC   Start Trial 2016-06-01 2016-06-03 AstraZeneca AB Inter partes review   Start Trial 2016-11-22 Jeffrey Robl   Start Trial
RE44,186 Aurobindo Pharma U.S.A., Inc.   Start Trial 2016-06-02 2016-06-02 ASTRAZENECA AB Inter partes review   Start Trial 2016-10-21 Jeffrey Robl   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
McKesson
Medtronic
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.